KALARIS THERAPEUTICS, INC. (KLRS) Free cash flow 2019–2025
KALARIS THERAPEUTICS, INC. (KLRS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$38.6MFY2025 · since FY2019: -$20.5M → -$38.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.6M | — |
| FY2021 | -$106.3M | -74.2% |
| FY2020 | -$61.0M | -197.9% |
| FY2019 | -$20.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More KLRS financial trends
KLRS RevenueKLRS Net incomeKLRS Net marginKLRS Gross profitKLRS Gross marginKLRS Operating incomeKLRS Operating marginKLRS Operating cash flowKLRS Capital expendituresKLRS Return on equityKLRS Stock buybacksKLRS Dividends paidKLRS Total assetsKLRS Total liabilitiesKLRS Shareholders’ equityKLRS overview →